Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$ftrp Graphic](https://lunarcrush.com/gi/w:26/t:$ftrp.png) $ftrp

CYBN's CYB003 Phase X trial shows promising results, with data expected soon. The company's advancements are generating significant buzz and engagement on social media.

### About $ftrp
FTRP is a financial symbol, likely representing a company or asset related to the psychedelic medicine sector.  

### Insights [#](/topic/$ftrp/insights)
- $ftrp mentions is at XX which is XXX% higher than it's daily average.
- $ftrp creators is at XX which is XXXXX% higher than it's daily average.
- $ftrp creators is up XXX% from the previous week.
- $ftrp mentions is up XX% from the previous week.
- $ftrp Creators hit a high of XX for the day
- $ftrp Creators hit an all time of XX for the day

### Engagements: XXXXX [#](/topic/$ftrp/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$ftrp/c:line/m:interactions.svg)  
[Engagements 24-Hour Chart Data](/topic/$ftrp/time-series/interactions.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XXX  
**1 Month**: XXXXXX +9.60%  
**1-Year High**: XXXXX on 2025-06-17  
**1-Year Low**: X on 2025-05-13  

| Social Network | X     |
| -------------- | -     |
| Engagements    | XXXXX |
  

  
  
### Mentions: XX [#](/topic/$ftrp/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$ftrp/c:line/m:posts_active.svg)  
[Mentions 24-Hour Chart Data](/topic/$ftrp/time-series/posts_active.tsv)  
**Current Value**: XX  
**Daily Average**: X  
**1 Week**: XX +60%  
**1 Month**: XX -XX%  
**1-Year High**: XXX on 2025-06-17  
**1-Year Low**: X on 2025-04-28  

| Social Network | X  |
| -------------- | -  |
| Mentions       | XX |
  

  
  
### Creators: XX [#](/topic/$ftrp/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$ftrp/c:line/m:contributors_active.svg)  
[Creators 24-Hour Chart Data](/topic/$ftrp/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning $ftrp in the last XX hours which is up XXX% from X in the previous XX hours
**Daily Average**: X  
**1 Week**: X +100%  
**1 Month**: X no change  
**1-Year High**: XX on 2025-07-19  
**1-Year Low**: X on 2025-04-28  

The most influential creators that mention $ftrp in the last XX hours

| Creator                                          | Rank | Followers | Posts | Engagements |
| -------                                          | ---- | --------- | ----- | ----------- |
| [@PsychedStocks](/creator/twitter/PsychedStocks) | X    | XXX       | X     | XXX         |

[View More](/list/creators/$ftrp/100)
  
  
### Sentiment: XX% [#](/topic/$ftrp/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$ftrp/c:line/m:sentiment.svg)  
[Sentiment 24-Hour Chart Data](/topic/$ftrp/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XXX%  
**1 Month**: XX% -X%  
**1-Year High**: XXX% on 2025-06-17  
**1-Year Low**: XX% on 2025-07-19  

**Most Supportive Themes**
- **CYBN Advancements:** (80%) CYBN's CYB003 Phase X trial is nearing completion, with data readout expected in Q2 2025, potentially leading to increased regulatory focus.
- **Positive Trial Results:** (20%) Positive developments in CYBN's CYB003 and CYB004 trials, including enrollment milestones and promising safety data, are driving positive sentiment.
  
**Most Critical Themes**
- **No Critical Themes:** (2%)  There are no critical themes identified in the provided context.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXX      | XX% | XXX     | XX% | XX       | X% |
|         |          |     |         |     |          |    |
| Total   | XXX      | XX% | XXX     | XX% | XX       | X% |
  


**Top assets mentioned**
In the posts about $ftrp in the last XX hours

[ATAI Life Sciences (ATAI)](/topic/$atai)
[DMarket (DMT)](/topic/$dmt)

**Top topics mentioned**
In the posts about $ftrp in the last XX hours

[$mnmd](/topic/$mnmd), [$cmps](/topic/$cmps), [$atai](/topic/$atai), [$cybn](/topic/$cybn), [momentum](/topic/momentum), [$ftrpf](/topic/$ftrpf), [$gbnh](/topic/$gbnh), [$rvv](/topic/$rvv), [$mcurf](/topic/$mcurf), [$mcur](/topic/$mcur), [stocks](/topic/stocks), [$seel](/topic/$seel), [$ghrs](/topic/$ghrs), [$mmed](/topic/$mmed), [$mycof](/topic/$mycof), [$enbi](/topic/$enbi), [$myco](/topic/$myco), [$spor](/topic/$spor), [abbv](/topic/abbv), [jnj](/topic/jnj), [spx](/topic/spx), [spy](/topic/spy), [cweb](/topic/cweb), [sol](/topic/sol), [compound](/topic/compound), [mental health](/topic/mental-health), [$psyk](/topic/$psyk), [$psil](/topic/$psil), [$agnpf](/topic/$agnpf), [$envb](/topic/$envb), [$psybf](/topic/$psybf), [$truff](/topic/$truff), [$phrm](/topic/$phrm), [$mset](/topic/$mset), [drugs](/topic/drugs), [$psyc](/topic/$psyc), [$xphy](/topic/$xphy), [stockmarket](/topic/stockmarket), [$shrmf](/topic/$shrmf), [$nova](/topic/$nova), [qqq](/topic/qqq), [$trypf](/topic/$trypf), [$psy](/topic/$psy), [investment](/topic/investment), [jan](/topic/jan), [fund manager](/topic/fund-manager), [$mmedf](/topic/$mmedf), [positions](/topic/positions), [$opthf](/topic/$opthf), [$clabf](/topic/$clabf), [$msos](/topic/$msos), [$dmttf](/topic/$dmttf), [50m](/topic/50m), [bloom](/topic/bloom), [$50m](/topic/$50m), [$phrrf](/topic/$phrrf), [$betrf](/topic/$betrf), [$epwcf](/topic/$epwcf), [$psycf](/topic/$psycf), [told](/topic/told), [breakthrough](/topic/breakthrough), [gme](/topic/gme), [opti](/topic/opti), [$iwin](/topic/$iwin), [$aiki](/topic/$aiki), [$tryp](/topic/$tryp), [$libff](/topic/$libff), [$clxpf](/topic/$clxpf), [litt](/topic/litt), [$psyb](/topic/$psyb), [$drug](/topic/$drug), [euro](/topic/euro), [$dcnpf](/topic/$dcnpf), [$bnoef](/topic/$bnoef), [$rvvtf](/topic/$rvvtf), [united states](/topic/united-states), [$dmt](/topic/$dmt), [gainers](/topic/gainers)

### Top Social Posts [#](/topic/$ftrp/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"$CYBN CYB003 Phase X trial at XX% enrollment Strong progress in depression treatment focus Clinical data readout anticipated Q3 $CMPS $MNMD $ATAI $FTRP"  
[@PsychedStocks](/creator/x/PsychedStocks) on [X](/post/tweet/1946229764252909627) 2025-07-18 15:25:09 UTC XXX followers, XXX engagements


"$CYBN CYB003 Phase X enrollment ahead of schedule Patient dosing progressing in depression trial Psilocybin pathway gaining regulatory momentum $CMPS $MNMD $ATAI $FTRP"  
[@PsychedStocks](/creator/x/PsychedStocks) on [X](/post/tweet/1946214753451254093) 2025-07-18 14:25:30 UTC XXX followers, XXX engagements


"$CYBN XXXX% price surge on strong trading volume Investor interest fueling momentum in psychedelics Potential for sector-leading advancements in medicine $CMPS $MNMD $ATAI $FTRP"  
[@PsychedStocks](/creator/x/PsychedStocks) on [X](/post/tweet/1946184533679751241) 2025-07-18 12:25:25 UTC XXX followers, XXX engagements


"$CYBN Strategic collaboration expanding pipeline reach Manufacturing partnership de-risks delivery Psychedelic medicine commercialization accelerating $CMPS $MNMD $ATAI $FTRP"  
[@PsychedStocks](/creator/x/PsychedStocks) on [X](/post/tweet/1945837308009189389) 2025-07-17 13:25:40 UTC XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$ftrp Graphic $ftrp

CYBN's CYB003 Phase X trial shows promising results, with data expected soon. The company's advancements are generating significant buzz and engagement on social media.

About $ftrp

FTRP is a financial symbol, likely representing a company or asset related to the psychedelic medicine sector.

Insights #

  • $ftrp mentions is at XX which is XXX% higher than it's daily average.
  • $ftrp creators is at XX which is XXXXX% higher than it's daily average.
  • $ftrp creators is up XXX% from the previous week.
  • $ftrp mentions is up XX% from the previous week.
  • $ftrp Creators hit a high of XX for the day
  • $ftrp Creators hit an all time of XX for the day

Engagements: XXXXX #


Engagements Line Chart
Engagements 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XXX
1 Month: XXXXXX +9.60%
1-Year High: XXXXX on 2025-06-17
1-Year Low: X on 2025-05-13

Social Network X
Engagements XXXXX

Mentions: XX #


Mentions Line Chart
Mentions 24-Hour Chart Data
Current Value: XX
Daily Average: X
1 Week: XX +60%
1 Month: XX -XX%
1-Year High: XXX on 2025-06-17
1-Year Low: X on 2025-04-28

Social Network X
Mentions XX

Creators: XX #


Creators Line Chart
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning $ftrp in the last XX hours which is up XXX% from X in the previous XX hours Daily Average: X
1 Week: X +100%
1 Month: X no change
1-Year High: XX on 2025-07-19
1-Year Low: X on 2025-04-28

The most influential creators that mention $ftrp in the last XX hours

Creator Rank Followers Posts Engagements
@PsychedStocks X XXX X XXX

View More

Sentiment: XX% #


Sentiment Line Chart
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XXX%
1 Month: XX% -X%
1-Year High: XXX% on 2025-06-17
1-Year Low: XX% on 2025-07-19

Most Supportive Themes

  • CYBN Advancements: (80%) CYBN's CYB003 Phase X trial is nearing completion, with data readout expected in Q2 2025, potentially leading to increased regulatory focus.
  • Positive Trial Results: (20%) Positive developments in CYBN's CYB003 and CYB004 trials, including enrollment milestones and promising safety data, are driving positive sentiment.

Most Critical Themes

  • No Critical Themes: (2%) There are no critical themes identified in the provided context.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXX XX% XXX XX% XX X%
Total XXX XX% XXX XX% XX X%

Top assets mentioned In the posts about $ftrp in the last XX hours

ATAI Life Sciences (ATAI) DMarket (DMT)

Top topics mentioned In the posts about $ftrp in the last XX hours

$mnmd, $cmps, $atai, $cybn, momentum, $ftrpf, $gbnh, $rvv, $mcurf, $mcur, stocks, $seel, $ghrs, $mmed, $mycof, $enbi, $myco, $spor, abbv, jnj, spx, spy, cweb, sol, compound, mental health, $psyk, $psil, $agnpf, $envb, $psybf, $truff, $phrm, $mset, drugs, $psyc, $xphy, stockmarket, $shrmf, $nova, qqq, $trypf, $psy, investment, jan, fund manager, $mmedf, positions, $opthf, $clabf, $msos, $dmttf, 50m, bloom, $50m, $phrrf, $betrf, $epwcf, $psycf, told, breakthrough, gme, opti, $iwin, $aiki, $tryp, $libff, $clxpf, litt, $psyb, $drug, euro, $dcnpf, $bnoef, $rvvtf, united states, $dmt, gainers

Top Social Posts #


Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"$CYBN CYB003 Phase X trial at XX% enrollment Strong progress in depression treatment focus Clinical data readout anticipated Q3 $CMPS $MNMD $ATAI $FTRP"
@PsychedStocks on X 2025-07-18 15:25:09 UTC XXX followers, XXX engagements

"$CYBN CYB003 Phase X enrollment ahead of schedule Patient dosing progressing in depression trial Psilocybin pathway gaining regulatory momentum $CMPS $MNMD $ATAI $FTRP"
@PsychedStocks on X 2025-07-18 14:25:30 UTC XXX followers, XXX engagements

"$CYBN XXXX% price surge on strong trading volume Investor interest fueling momentum in psychedelics Potential for sector-leading advancements in medicine $CMPS $MNMD $ATAI $FTRP"
@PsychedStocks on X 2025-07-18 12:25:25 UTC XXX followers, XXX engagements

"$CYBN Strategic collaboration expanding pipeline reach Manufacturing partnership de-risks delivery Psychedelic medicine commercialization accelerating $CMPS $MNMD $ATAI $FTRP"
@PsychedStocks on X 2025-07-17 13:25:40 UTC XXX followers, XXX engagements

$ftrp
/topic/$ftrp